Cosmos Health Inc. COSM
Other Pharmaceuticals · data as of November 13, 2026
Cosmos Health Inc. (COSM) is a healthcare company listed in the US with a market value of about $326M. In the twelve months to June 30, 2026 it had revenue of $74M and net income of -$24M, a net margin of -33.1%.
Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is future growth (2/5); the weakest is value (0/5).
Key numbers: 5-year revenue growth of 3% a year, a 5-year average ROIC of -42%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 97% below the current price.
About Cosmos Health
Cosmos Health is listed in the US and classified in other pharmaceuticals. Revenue went from $8M in 2014 to $65M in 2025, growth of about 21.5% a year. It was profitable in 1 of the last 10 years in our data. Its share count rose by 1471% over three years (dilution for shareholders). It spends 1% of revenue on research and development.
Score: 0.8 / 5
Checks passed
- Revenue growth above 10% last year
- Profit margin improving
- More cash than debt, or low debt to equity
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $74M | $65M | $54M | $53M | $50M | $56M | $55M | $40M | $37M | $30M | $7M |
| Net income | -$24M | -$19M | -$16M | -$19M | -$14M | -$8M | $820786 | -$3M | -$9M | -$6M | -$601002 |
| Free cash flow | -$10M | -$9M | -$8M | -$17M | -$15M | -$8M | -$12M | — | -$2M | -$9M | -$2M |
| EPS (diluted) | $-0.64 | $-0.63 | $-1.17 | $-2.15 | $-33.16 | $-23.74 | $1.50 | $-6.25 | $-17.00 | $-12.25 | $2018526.23 |
| Net margin | -33.1% | -29.3% | -29.7% | -34.7% | -27.5% | -14.2% | 1.5% | -8.3% | -24.4% | -20.7% | -8.9% |
| ROIC | — | -73.3% | -53.0% | -52.2% | -15.5% | -15.5% | 11.0% | -3.3% | -18.9% | — | — |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Is Cosmos Health stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 97% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Cosmos Health pay a dividend?
Not currently.
Is Cosmos Health a good stock to buy?
We do not give buy or sell advice. Cosmos Health scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.